Psilocybin and mental imagery for young people who self-harm
Treatments studied
Part of Mental health clinical trials.
This study tests whether a single dose of psilocybin (the active ingredient in magic mushrooms) combined with a mental imagery therapy can help reduce self-harm thoughts and behaviors in people ages 16–25. You would receive the drug in a safe clinic setting and complete several therapy sessions and questionnaires over a few weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 16 to 25 years old.
- You must have harmed yourself at least twice in your life and at least once in the past month.
- You must have had upsetting mental images related to self-harm in the past six weeks.
- You must be comfortable talking about self-harm and mental health with the study team.
- You cannot have taken any psychedelic drugs (like LSD or psilocybin) before.
- You must not be taking certain medications (like antidepressants, antipsychotics, or tramadol) that could interact with psilocybin.
- You must have a normal heart ECG and blood pressure, as checked by the study doctor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two different doses of psilocybin, a substance that may help change thinking patterns, given alongside psychological support to young adults with anorexia nervosa. It aims to see if it is safe and helpful for weight recovery and mental health.
This study tests whether combining mindfulness training with a single dose of psilocybin (a psychedelic found in certain mushrooms) can help healthy adults. It aims to explore how these two approaches together might improve well-being.
This trial tests if psilocybin, a substance found in certain mushrooms, can help people with various mental health symptoms that affect daily life. You would take a single dose in a supervised setting and be monitored for changes in your mood and well-being.
This trial tests how psilocybin, a psychedelic substance, affects your thinking, memory, and brain activity. Researchers want to understand these effects in healthy adults who have used psychedelics before.
This trial tests whether a single dose of psilocybin (a psychedelic substance) can help treat anorexia nervosa in young adults. It involves taking the medication in a safe, supervised setting and participating in therapy sessions with a support person.
This Phase 1/2 study tests psilocybin to see how it affects brain signals and the “content” of thoughts while you are monitored during the study. Because participants must be generally healthy and mentally stable, it may be an option if you meet those safety and medication rules and are comfortable having your brain activity measured.
Hear when a new Self Harm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.